FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116746706> ?p ?o ?g. }

• W2116746706 endingPage "741" @default.
• W2116746706 startingPage "730" @default.
• W2116746706 abstract "Tumor microenvironment (TM) is an essential element in prostate cancer (PCA), offering unique opportunities for its prevention. TM includes naïve fibroblasts that are recruited by nascent neoplastic lesion and altered into ‘cancer-associated fibroblasts’ (CAFs) that promote PCA. A better understanding and targeting of interaction between PCA cells and fibroblasts and inhibiting CAF phenotype through non-toxic agents are novel approaches to prevent PCA progression. One well-studied cancer chemopreventive agent is silibinin, and thus, we examined its efficacy against PCA cells-mediated differentiation of naïve fibroblasts into a myofibroblastic-phenotype similar to that found in CAFs. Silibinin's direct inhibitory effect on the phenotype of CAFs derived directly from PCA patients was also assessed. Human prostate stromal cells (PrSCs) exposed to control conditioned media (CCM) from human PCA PC3 cells showed more invasiveness, with increased alpha-smooth muscle actin (α-SMA) and vimentin expression, and differentiation into a phenotype we identified in CAFs. Importantly, silibinin (at physiologically achievable concentrations) inhibited α-SMA expression and invasiveness in differentiated fibroblasts and prostate CAFs directly, as well as indirectly by targeting PCA cells. The observed increase in α-SMA and CAF-like phenotype was transforming growth factor (TGF) β2 dependent, which was strongly inhibited by silibinin. Furthermore, induction of α-SMA and CAF phenotype by CCM were also strongly inhibited by a TGFβ2-neutralizing antibody. The inhibitory effect of silibinin on TGFβ2 expression and CAF-like biomarkers was also observed in PC3 tumors. Together, these findings highlight the potential usefulness of silibinin in PCA prevention through targeting the CAF phenotype in the prostate TM. © 2014 Wiley Periodicals, Inc." @default.
• W2116746706 created "2016-06-24" @default.
• W2116746706 creator A5005377627 @default.
• W2116746706 creator A5005855266 @default.
• W2116746706 creator A5007029060 @default.
• W2116746706 creator A5013566244 @default.
• W2116746706 creator A5027734680 @default.
• W2116746706 creator A5048444823 @default.
• W2116746706 creator A5053069943 @default.
• W2116746706 creator A5059572873 @default.
• W2116746706 creator A5079388843 @default.
• W2116746706 date "2014-02-24" @default.
• W2116746706 modified "2023-10-14" @default.
• W2116746706 title "Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2" @default.
• W2116746706 cites W1911919368 @default.
• W2116746706 cites W1964195356 @default.
• W2116746706 cites W1964794241 @default.
• W2116746706 cites W1983819045 @default.
• W2116746706 cites W1984162437 @default.
• W2116746706 cites W1984614875 @default.
• W2116746706 cites W2004273718 @default.
• W2116746706 cites W2009673421 @default.
• W2116746706 cites W2020302072 @default.
• W2116746706 cites W2020667072 @default.
• W2116746706 cites W2031171659 @default.
• W2116746706 cites W2031459560 @default.
• W2116746706 cites W2036101334 @default.
• W2116746706 cites W2039299190 @default.
• W2116746706 cites W2039489315 @default.
• W2116746706 cites W2052147002 @default.
• W2116746706 cites W2059724367 @default.
• W2116746706 cites W2079347556 @default.
• W2116746706 cites W2080589329 @default.
• W2116746706 cites W2083839175 @default.
• W2116746706 cites W2085033745 @default.
• W2116746706 cites W2086585598 @default.
• W2116746706 cites W2089415609 @default.
• W2116746706 cites W2095538170 @default.
• W2116746706 cites W2096764577 @default.
• W2116746706 cites W2098713848 @default.
• W2116746706 cites W2105564769 @default.
• W2116746706 cites W2114375069 @default.
• W2116746706 cites W2123105952 @default.
• W2116746706 cites W2130352141 @default.
• W2116746706 cites W2138029397 @default.
• W2116746706 cites W2140481064 @default.
• W2116746706 cites W2141662760 @default.
• W2116746706 cites W2143006632 @default.
• W2116746706 cites W2144877334 @default.
• W2116746706 cites W2153167297 @default.
• W2116746706 cites W2161744213 @default.
• W2116746706 cites W2161817637 @default.
• W2116746706 cites W2165948908 @default.
• W2116746706 cites W2167474785 @default.
• W2116746706 doi "https://doi.org/10.1002/mc.22135" @default.
• W2116746706 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4208986" @default.
• W2116746706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24615813" @default.
• W2116746706 hasPublicationYear "2014" @default.
• W2116746706 type Work @default.
• W2116746706 sameAs 2116746706 @default.
• W2116746706 citedByCount "31" @default.
• W2116746706 countsByYear W21167467062014 @default.
• W2116746706 countsByYear W21167467062015 @default.
• W2116746706 countsByYear W21167467062016 @default.
• W2116746706 countsByYear W21167467062017 @default.
• W2116746706 countsByYear W21167467062018 @default.
• W2116746706 countsByYear W21167467062019 @default.
• W2116746706 countsByYear W21167467062020 @default.
• W2116746706 countsByYear W21167467062021 @default.
• W2116746706 countsByYear W21167467062022 @default.
• W2116746706 countsByYear W21167467062023 @default.
• W2116746706 crossrefType "journal-article" @default.
• W2116746706 hasAuthorship W2116746706A5005377627 @default.
• W2116746706 hasAuthorship W2116746706A5005855266 @default.
• W2116746706 hasAuthorship W2116746706A5007029060 @default.
• W2116746706 hasAuthorship W2116746706A5013566244 @default.
• W2116746706 hasAuthorship W2116746706A5027734680 @default.
• W2116746706 hasAuthorship W2116746706A5048444823 @default.
• W2116746706 hasAuthorship W2116746706A5053069943 @default.
• W2116746706 hasAuthorship W2116746706A5059572873 @default.
• W2116746706 hasAuthorship W2116746706A5079388843 @default.
• W2116746706 hasBestOaLocation W21167467062 @default.
• W2116746706 hasConcept C104317684 @default.
• W2116746706 hasConcept C111798993 @default.
• W2116746706 hasConcept C118131993 @default.
• W2116746706 hasConcept C121608353 @default.
• W2116746706 hasConcept C127716648 @default.
• W2116746706 hasConcept C142724271 @default.
• W2116746706 hasConcept C147447768 @default.
• W2116746706 hasConcept C16930146 @default.
• W2116746706 hasConcept C203014093 @default.
• W2116746706 hasConcept C204232928 @default.
• W2116746706 hasConcept C207865475 @default.
• W2116746706 hasConcept C2776107976 @default.
• W2116746706 hasConcept C2777130413 @default.
• W2116746706 hasConcept C2780192828 @default.
• W2116746706 hasConcept C2780381497 @default.
• W2116746706 hasConcept C2780559512 @default.

• next